Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terazosin and Lisosan-G in Parkinson's Disease
NCT05855577Phase 4Not yet recruiting
- Sponsor
- Fondazione Santa Lucia IRCCS
- Start
- Dec 2023
- Primary completion
- May 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of terazosin, Lisosan G in Parkinson's disease (PD), sponsored by Fondazione Santa Lucia IRCCS. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
terazosinLisosan G
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT05855577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05855577.